GlassScriptPhysician profile
Richard Alan Compton
NPI 1215381777
$2,408.02
in general payments reported to CMS, 2019-2025
21 companies · $610 in 2025
The $610 reported for 2025 was more than what 92% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $703 · 2022: $344 · 2023: $225 · 2024: $526 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $545.81 | 2021-2025 | |
| Lilly USA, LLC | $465.24 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $296.64 | 2021-2025 | Repatha, Evenity, Prolia |
| Glaxosmithkline, LLC. | $173.22 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Mayne Pharma Commercial LLC | $162.70 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $145.75 | 2021-2025 | Trintellix |
| Exact Sciences Corporation | $102.00 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $78.37 | 2023-2024 | Rybelsus, Ozempic |
| Sanofi Pasteur INC. | $60.51 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $56.48 | 2021 | |
| Mylan Specialty L.P. | $43.41 | 2021-2022 | |
| Pfizer INC. | $43.12 | 2021-2025 | |
| Vertical Pharmaceuticals, LLC | $34.91 | 2023-2024 | Dsuvia |
| Linus Health, INC. | $31.73 | 2022 | |
| Lundbeck LLC | $30.77 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $30.08 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.66 | 2022 | |
| Viatris Specialty LLC | $23.56 | 2025 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.31 | 2021 | |
| Radius Health, INC. | $19.40 | 2023 | Tymlos |
| Hologic Sales and Service, LLC | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Compton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.